PHARMACEUTICALLY ELEGANT Trademark
Trademark Overview
On Wednesday, January 19, 2022, a trademark application was filed for PHARMACEUTICALLY ELEGANT with the United States Patent and Trademark Office. The USPTO has given the PHARMACEUTICALLY ELEGANT trademark a serial number of 97227033. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, May 30, 2023. This trademark is owned by Aquestive Therapeutics, Inc.. The PHARMACEUTICALLY ELEGANT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reac...
Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development
General Information
| Serial Number | 97227033 |
| Word Mark | PHARMACEUTICALLY ELEGANT |
| Filing Date | Wednesday, January 19, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, May 30, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 10, 2022 |
Trademark Statements
| Goods and Services | Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches |
| Disclaimer with Predetermined Text | "PHARMACEUTICALLY" |
| Goods and Services | Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 25, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Aquestive Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
| Party Name | Aquestive Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
Trademark Events
| Event Date | Event Description |
| Thursday, June 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 30, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, May 30, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, May 30, 2023 | TEAS EXTENSION RECEIVED |
| Monday, February 13, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 14, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, December 14, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, December 14, 2022 | TEAS EXTENSION RECEIVED |
| Thursday, August 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, August 25, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, August 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 5, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 10, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 10, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 20, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, April 1, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 16, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 22, 2022 | NEW APPLICATION ENTERED |
